NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
The role of clinical pharmacology in molecular geneticsPROBLEM: Discovering the causes of unusual phenotypes in human subjects is an important aspect of patient-oriented research. MATERIAL: The tools of clinical pharmacology are uniquely useful in addressing these problems. PATIENTS, SUBJECTS, OR CASE HISTORIES: We evaluated a 42-year-old patient with lifelong orthostatic hypotension and ptosis of the eyelids. He underwent a series of biochemical, physiological, and pharmacological tests outlined in this article. RESULTS: These studies indicated that sympathetic innervation was intact but that the sympathetic neurotransmitter was dopamine rather than norepinephrine. These results demonstrated that dopamine-beta-hydroxylase deficiency underlies the clinical abnormalities of this patient. CONCLUSION: In selected individuals with unusual phenotypes, the techniques of clinical chemistry and clinical pharmacology can define the nature of the defect at almost the resolution of the human genome.
Document ID
20040172993
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Robertson, D.
(Vanderbilt University Nashville, Tennessee 37232-2195, United States)
Date Acquired
August 22, 2013
Publication Date
April 1, 1997
Publication Information
Publication: International journal of clinical pharmacology and therapeutics
Volume: 35
Issue: 4
ISSN: 0946-1965
Subject Category
Aerospace Medicine
Funding Number(s)
CONTRACT_GRANT: RR00095S
CONTRACT_GRANT: HL 44S89
Distribution Limits
Public
Copyright
Other
Keywords
NASA Discipline Regulatory Physiology
Case Reports
Non-NASA Center

Available Downloads

There are no available downloads for this record.
No Preview Available